Covaxin: Manufacturer, dose schedule, efficacy rate, possible side effects and price in India
India
Updated: Sunday, January 17, 2021, 19:42 [IST]
New Delhi, Jan 16: Covaxin has been developed by Indian biotechnology company Bharat Biotech and clinical research body Indian Council of Medical Research (ICMR).
It is being said, Covaxin an inactivated vaccine which follows one of the oldest methods for vaccinating people.
File Photo
Covaxin injects inactivated viruses in the body to trigger an immune response. These whole batches of coronavirus must be grown, killed using a chemical or heat and then made into a vaccine, making it a longer process.
Effectiveness
Covaxin is safe and provides a robust immune response, said Drugs Controller General of India VG Somani. The vaccine is yet to complete late-stage human clinical trials in India and no efficacy rate has yet been made public.